Gujarat Kidney & Super Speciality Q2 FY27 Results
Gujarat Kidney and Super Speciality Ltd · Investor Presentation · 05 Nov 2026, 4:44 pm
Gujarat Kidney & Super Speciality Q2 FY27 Results Gujarat Kidney & Super Speciality reported Q2 FY27 revenue from operations of ₹3,809 lakhs (+194.6% YoY, +11.1% QoQ), with EBITDA rising 99.4% YoY to ₹1,022 lakhs (26.8% margin) and PAT surging 129.4% YoY to ₹660 lakhs. For H1 FY27, revenue reached ₹7,238 lakhs (+156.8% YoY) and PAT stood at ₹1,192 lakhs (+44.0% YoY). Growth was driven by network acquisitions, deploying ₹1,669 lakhs in H1, alongside a 51% acquisition in Dubai's Blue Tree Clinics. As of 30th Sep'26, the company maintained a net cash position of ₹1,488 lakhs.
Original exchange filing (PDF)
More announcements from Gujarat Kidney and Super Speciality Ltd
- Transcript of Earning Call conducted on 05/11/2026 · 11 Nov 2026
- Audio recording of earning call · 05 Nov 2026
- Investor Presentation for scheduled Conference Call on November 05, 2026 · 05 Nov 2026
- Statement of Deviation and Variation submitted for the quarter ended on September 30, 2026. · 05 Nov 2026
- Monitoring Report for the Quarter ended September 30, 2026 · 05 Nov 2026
- Unaudited Standalone and Consolidated Financial Results for the Quarter ended September 30, 2026 · 05 Nov 2026
- Gujarat Kidney And Super Speciality Limited has submitted to the Exchange, the unaudited Standalone and Consolidated financial results for the period ended September 30, 2026. · 05 Nov 2026
- Earning Con-call · 05 Nov 2026
